Inventor · Princeton, NJ, US

Ryan M. Moslin

16Patents
7h-index
23Co-inventors
62Inventor score

Filing activity: Nov 7, 2013 → Sep 5, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US9505748B2 Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses Chemistry; Metallurgy 15 Active
US9663467B2 Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses Chemistry; Metallurgy 13 Active
US10000480B2 Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses Chemistry; Metallurgy 13 Active
US9315494B2 Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses Chemistry; Metallurgy 12 Active
US9540333B2 Alkyl amide-substituted pyrimidine compounds useful in the modulation of IL-12, IL-23 and/or IFNα Chemistry; Metallurgy 10 Active
USRE47929E1 Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses General 9 Active
US11866414B2 Substituted heterocyclic compounds Chemistry; Metallurgy 7 Active
US11021475B2 Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses Chemistry; Metallurgy 6 Active
US9987266B2 Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses Chemistry; Metallurgy 6 Active
US10273237B2 Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN-α responses Chemistry; Metallurgy 3 Active
US11021462B2 Sulfone pyridine alkyl amide-substituted heteroaryl compounds Chemistry; Metallurgy 3 Active
US10479793B2 Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses Human Necessities 1 Active
US11787779B2 Sulfone pyridine alkyl amide-substituted heteroaryl compounds Chemistry; Metallurgy 1 Active
US12365667B2 Sulfone pyridine alkyl amide-substituted heteroaryl compounds Chemistry; Metallurgy 0 Active
US11884650B2 Substituted heterocyclic compounds Chemistry; Metallurgy 0 Active
US12240840B2 Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.